Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Cancer stem cells and side population cells in breast cancer and metastasis.

Britton KM, Kirby JA, Lennard TW, Meeson AP.

Cancers (Basel). 2011 Apr 19;3(2):2106-30. doi: 10.3390/cancers3022106.

PMID:
24212798
[PubMed]
Free PMC Article
2.

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.

Malcovati L, Hellström-Lindberg E, Bowen D, Adès L, Cermak J, Del Cañizo C, Della Porta MG, Fenaux P, Gattermann N, Germing U, Jansen JH, Mittelman M, Mufti G, Platzbecker U, Sanz GF, Selleslag D, Skov-Holm M, Stauder R, Symeonidis A, van de Loosdrecht AA, de Witte T, Cazzola M; European Leukemia Net.

Blood. 2013 Oct 24;122(17):2943-64. doi: 10.1182/blood-2013-03-492884. Epub 2013 Aug 26.

PMID:
23980065
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The FLT3 inhibitor quizartinib inhibits ABCG2 at pharmacologically relevant concentrations, with implications for both chemosensitization and adverse drug interactions.

Bhullar J, Natarajan K, Shukla S, Mathias TJ, Sadowska M, Ambudkar SV, Baer MR.

PLoS One. 2013 Aug 14;8(8):e71266. doi: 10.1371/journal.pone.0071266. eCollection 2013.

PMID:
23967177
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Myelodysplastic syndromes: clinical practice guidelines in oncology.

Greenberg PL, Attar E, Bennett JM, Bloomfield CD, Borate U, De Castro CM, Deeg HJ, Frankfurt O, Gaensler K, Garcia-Manero G, Gore SD, Head D, Komrokji R, Maness LJ, Millenson M, O'Donnell MR, Shami PJ, Stein BL, Stone RM, Thompson JE, Westervelt P, Wheeler B, Shead DA, Naganuma M.

J Natl Compr Canc Netw. 2013 Jul;11(7):838-74.

PMID:
23847220
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms.

Natarajan K, Bhullar J, Shukla S, Burcu M, Chen ZS, Ambudkar SV, Baer MR.

Biochem Pharmacol. 2013 Feb 15;85(4):514-24. doi: 10.1016/j.bcp.2012.12.006. Epub 2012 Dec 19.

PMID:
23261525
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Analysis of the interaction of induction regimens with p-glycoprotein expression in patients with acute myeloid leukaemia: results from the MRC AML15 trial.

Pallis M, Hills R, White P, Grundy M, Russell N, Burnett A.

Blood Cancer J. 2011 Jun;1(6):e23. doi: 10.1038/bcj.2011.23. Epub 2011 Jun 17.

PMID:
22829167
[PubMed]
Free PMC Article
7.

High TOP2B/TOP2A expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia.

Song JH, Kweon SH, Kim HJ, Lee TH, Min WS, Kim HJ, Kim YK, Hwang SY, Kim TS.

Br J Cancer. 2012 Jun 26;107(1):108-15. doi: 10.1038/bjc.2012.206. Epub 2012 May 24.

PMID:
22627319
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Drug resistance: still a daunting challenge to the successful treatment of AML.

Shaffer BC, Gillet JP, Patel C, Baer MR, Bates SE, Gottesman MM.

Drug Resist Updat. 2012 Feb-Apr;15(1-2):62-9. doi: 10.1016/j.drup.2012.02.001. Epub 2012 Mar 11. Review.

PMID:
22409994
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia.

Uy GL, Rettig MP, Motabi IH, McFarland K, Trinkaus KM, Hladnik LM, Kulkarni S, Abboud CN, Cashen AF, Stockerl-Goldstein KE, Vij R, Westervelt P, DiPersio JF.

Blood. 2012 Apr 26;119(17):3917-24. doi: 10.1182/blood-2011-10-383406. Epub 2012 Feb 2.

PMID:
22308295
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the aurora-B kinase inhibitor barasertib-hQPA.

Grundy M, Seedhouse C, Russell NH, Pallis M.

BMC Cancer. 2011 Jun 16;11:254. doi: 10.1186/1471-2407-11-254.

PMID:
21679421
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

ATP Binding Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients.

Marzac C, Garrido E, Tang R, Fava F, Hirsch P, De Benedictis C, Corre E, Lapusan S, Lallemand JY, Marie JP, Jacquet E, Legrand O.

Haematologica. 2011 Sep;96(9):1293-301. doi: 10.3324/haematol.2010.031823. Epub 2011 May 23.

PMID:
21606172
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes.

Greenberg PL, Attar E, Bennett JM, Bloomfield CD, De Castro CM, Deeg HJ, Foran JM, Gaensler K, Garcia-Manero G, Gore SD, Head D, Komrokji R, Maness LJ, Millenson M, Nimer SD, O'Donnell MR, Schroeder MA, Shami PJ, Stone RM, Thompson JE, Westervelt P; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2011 Jan;9(1):30-56.

PMID:
21233243
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

ABC transporters: unvalidated therapeutic targets in cancer and the CNS.

Robey RW, Massey PR, Amiri-Kordestani L, Bates SE.

Anticancer Agents Med Chem. 2010 Oct 1;10(8):625-33. Review.

PMID:
21189132
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999.

Cripe LD, Uno H, Paietta EM, Litzow MR, Ketterling RP, Bennett JM, Rowe JM, Lazarus HM, Luger S, Tallman MS.

Blood. 2010 Nov 18;116(20):4077-85. doi: 10.1182/blood-2010-04-277269. Epub 2010 Aug 17.

PMID:
20716770
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Challenges in treating older patients with acute myeloid leukemia.

Eleni LD, Nicholas ZC, Alexandros S.

J Oncol. 2010;2010:943823. doi: 10.1155/2010/943823. Epub 2010 Jun 10.

PMID:
20628485
[PubMed]
Free PMC Article
16.

P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808.

Kolitz JE, George SL, Marcucci G, Vij R, Powell BL, Allen SL, DeAngelo DJ, Shea TC, Stock W, Baer MR, Hars V, Maharry K, Hoke E, Vardiman JW, Bloomfield CD, Larson RA; Cancer and Leukemia Group B.

Blood. 2010 Sep 2;116(9):1413-21. doi: 10.1182/blood-2009-07-229492. Epub 2010 Jun 3.

PMID:
20522709
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.

McCubrey JA, Abrams SL, Stadelman K, Chappell WH, Lahair M, Ferland RA, Steelman LS.

Adv Enzyme Regul. 2010;50(1):285-307. doi: 10.1016/j.advenzreg.2009.10.016. Epub 2009 Nov 4. Review. No abstract available.

PMID:
19895837
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia.

Chauncey TR, Gundacker H, Shadman M, List AF, Dakhil SR, Erba HP, Slovak ML, Chen IM, Willman CL, Kopecky KJ, Appelbaum FR.

Br J Haematol. 2010 Jan;148(1):48-58. doi: 10.1111/j.1365-2141.2009.07919.x. Epub 2009 Oct 11.

PMID:
19821823
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996).

Greenberg PL, Sun Z, Miller KB, Bennett JM, Tallman MS, Dewald G, Paietta E, van der Jagt R, Houston J, Thomas ML, Cella D, Rowe JM.

Blood. 2009 Sep 17;114(12):2393-400. doi: 10.1182/blood-2009-03-211797. Epub 2009 Jun 29.

PMID:
19564636
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.

Dai CL, Liang YJ, Chen LM, Zhang X, Deng WJ, Su XD, Shi Z, Wu CP, Ashby CR Jr, Akiyama S, Ambudkar SV, Chen ZS, Fu LW.

Biochem Pharmacol. 2009 Aug 15;78(4):355-64. doi: 10.1016/j.bcp.2009.04.023. Epub 2009 May 3.

PMID:
19410561
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk